PEspeaks

Jul 18, 2018
Research-based companies in Europe look as though they have lost one battle on preserving incentives for innovation – but the bigger war is only now getting underway, writes Reflector.
Jul 09, 2018
Pharmaceutical Executive
With blockchain still in the potential but not proven area of the pharma enterprise, when is the technology the right choice for you?
Jul 07, 2018
Pharmaceutical Executive
Peter Young explores the prospects—and related challenges—for Chinese life science as it aggressively pursues new growth areas.
Jul 02, 2018
Pharmaceutical Executive
Pharm Exec’s 18th annual listing of the top biopharma players shows that most of the familiar placeholders are holding their ground as they weigh a changing business climate with new opportunities for growth.
Jun 29, 2018
Pharmaceutical Executive
Korean biotech opens first U.S. headquarters in New Jersey to better control clinical trials as it looks for strategic partnerships in the U.S.
Jun 29, 2018
Pharmaceutical Executive
HHS and CMS have committed to support value-based purchasing of prescription drugs in Medicaid, despite headlines of CMS’s rejection of a Massachusetts request to make changes in its Medicaid prescription drug benefit.
Jun 20, 2018
Legislators have requested that FDA do more to prevent drug shortages.
Jun 19, 2018
Figuring out the workings of the EU in topics related to health can be akin to deciphering Egyptian hieroglyphs, making it challenging for companies to plan ahead, writes Reflector.
Jun 19, 2018
Pharmaceutical Executive
Jonathan Kraft shares his family's secrets on what it takes to lead a successful organization, while also creating lasting brand power.
Jun 14, 2018
Pharmaceutical Executive
Reputation Institute study finds that the reputation of pharma companies is in decline and might get worse before it gets better.
native1_300x100
lorem ipsum